China Jo-Jo Drugstores, Inc. (CJJD)
USD 1.52
(-5.59%)
USD 1.52
(-5.59%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 6.4 Million USD | 0.0% |
| 2023 | 7.76 Million USD | -15.54% |
| 2022 | 9.19 Million USD | -45.93% |
| 2021 | 17.01 Million USD | -26.57% |
| 2020 | 23.16 Million USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q4 | 6.4 Million USD | -100.0% |
| 2024 Q1 | 7.44 Million USD | 0.0% |
| 2024 Q3 | 6.4 Million USD | 0.0% |
| 2024 FY | 6.4 Million USD | -17.56% |
| 2024 Q2 | 7.44 Million USD | -100.0% |
| 2023 Q3 | 7.76 Million USD | -8.3% |
| 2023 FY | 7.76 Million USD | -15.54% |
| 2023 Q1 | 8.47 Million USD | -7.89% |
| 2023 Q2 | 8.47 Million USD | 0.0% |
| 2023 Q4 | 7.76 Million USD | 0.0% |
| 2022 Q1 | 16.65 Million USD | -2.1% |
| 2022 FY | 9.19 Million USD | -45.93% |
| 2022 Q4 | 9.19 Million USD | 0.0% |
| 2022 Q3 | 9.19 Million USD | -44.78% |
| 2022 Q2 | 16.65 Million USD | 0.0% |
| 2021 Q1 | 20.46 Million USD | -11.64% |
| 2021 Q3 | 20.58 Million USD | 5.07% |
| 2021 FY | 17.01 Million USD | -26.57% |
| 2021 Q2 | 19.58 Million USD | -4.29% |
| 2021 Q4 | 17.01 Million USD | -17.36% |
| 2020 Q2 | 12.21 Million USD | 54.24% |
| 2020 FY | 23.16 Million USD | 0.0% |
| 2020 Q3 | 17.44 Million USD | 42.82% |
| 2020 Q4 | 23.16 Million USD | 32.8% |
| 2020 Q1 | 7.91 Million USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q2 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 19.93 Thousand USD | -32022.081% |
| BIMI International Medical Inc. | 2.88 Million USD | -121.622% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 183.17 Million USD | 96.504% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 183.17 Million USD | 96.504% |
| Leafly Holdings, Inc. | 29.08 Million USD | 77.982% |
| Leafly Holdings, Inc. | 29.08 Million USD | 77.982% |
| LifeMD, Inc. | 17.92 Million USD | 64.28% |
| LifeMD, Inc. | 17.92 Million USD | 64.28% |
| TRxADE HEALTH, Inc. | 434.2 Thousand USD | -1374.847% |
| PetMed Express, Inc. | 995 Thousand USD | -543.604% |
| Walgreens Boots Alliance, Inc. | 8.04 Billion USD | 99.92% |